Radiopharmaceutical Regulatory Updates and Pharmacy Law

Course overview

UAN: 0018-0000-18-208-H03-P & T RELEASE: 10/22/2018 EXPIRE: 10/22/2021 CREDITS: 2.0 LEARNING OBJECTIVES: 1. Describe the development of USP General Chapter <797>. 2. Describe recent problems involving sterile compounding and responses to those problems. 3. Describe special issues related to compounding of radiopharmaceuticals. 4. Describe focus of forthcoming USP <825>. 5. Explain how to integrate basic quality and safety concepts into nuclear medicine 6. Discuss current nuclear medicine practices impacted by TJC 7. List QAPI ideas for nuclear medicine 8. Recognize risk and establish actions to mitigate risk NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the "Radiopharmacy Portal" a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $195 for nuclear pharmacists and $95 for nuclear pharmacy technicians.